stocktools
Offerings // Aspire Biopharma Holdings, Inc.

ASBP offering history

Every offering-related filing in Aspire Biopharma Holdings, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 220 filings back to Mar 16, 2021.

Last executed offering
Aug 10, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Apr 10, 2026
S-1/A — capacity, not a sale
Executed, last 12 months
6
424B pricings + 8-K 3.02 sales
Registered, last 12 months
5
S-1/S-3/F-series registrations
DateFilingWhat it means
Aug 10, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 14, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 10, 2026S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Feb 17, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Feb 12, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 30, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 6, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Dec 12, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 3, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Nov 14, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 29, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 26, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 26, 2025S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Sep 18, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
May 29, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
May 13, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Apr 21, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 9, 2025S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Feb 21, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 20, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 14, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 14, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 26, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 2, 2024RW →WITHDRAWNRegistration withdrawn
Feb 23, 20228-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Feb 22, 2022424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Feb 17, 2022EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 14, 2022S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Dec 30, 2021S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
ASBP offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ASBP workspace →
ASBP offering FAQ

When did ASBP last execute an offering?

Per SEC filings, Aspire Biopharma Holdings, Inc.'s most recent priced offering document is a 8-K filed 2026-08-10. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ASBP last announce or register an offering?

The most recent registration is a S-1/A filed 2026-04-10. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.